Your browser is no longer supported. Please, upgrade your browser.
Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Index- P/E16.96 EPS (ttm)2.15 Insider Own26.40% Shs Outstand2.01B Perf Week1.25%
Market Cap73.60B Forward P/E15.33 EPS next Y2.38 Insider Trans0.00% Shs Float1.30B Perf Month10.23%
Income5.46B PEG1.77 EPS next Q0.53 Inst Own8.20% Short Float0.14% Perf Quarter5.28%
Sales16.10B P/S4.57 EPS this Y10.60% Inst Trans0.20% Short Ratio0.77 Perf Half Y-9.19%
Book/sh2.59 P/B14.11 EPS next Y11.25% ROA42.70% Target Price36.70 Perf Year-33.76%
Cash/sh1.48 P/C24.69 EPS next 5Y9.60% ROE91.10% 52W Range30.29 - 55.78 Perf YTD3.93%
Dividend1.12 P/FCF31.52 EPS past 5Y20.10% ROI84.70% 52W High-34.50% Beta0.72
Dividend %3.07% Quick Ratio1.00 Sales past 5Y11.00% Gross Margin84.60% 52W Low20.65% ATR0.50
Employees41971 Current Ratio1.30 Sales Q/Q2.40% Oper. Margin43.30% RSI (14)63.03 Volatility0.83% 1.09%
OptionableYes Debt/Eq0.01 EPS Q/Q6.70% Profit Margin33.90% Rel Volume0.57 Prev Close35.88
ShortableYes LT Debt/Eq0.00 EarningsMay 03 BMO Payout45.20% Avg Volume2.44M Price36.54
Recom4.00 SMA203.57% SMA506.26% SMA200-6.33% Volume1,396,883 Change1.84%
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
Apr-19-17 09:21AM  3 Beaten-Up Healthcare Stocks: Are They Bargains? Motley Fool
Apr-18-17 05:54PM  Citigroup Commercial Mortgage Trust 2017-P7 -- Moody's Assigns Definitive Ratings to Nine CMBS Classes of Citigroup Commercial Mortgage Trust 2017-P7 Moody's
11:41AM  High-Yield Healthcare Investments You Can Buy Right Now Motley Fool
Apr-17-17 09:33AM  Novo Nordisk Invites the Community to Unmask Everyday Heroes in Recognition of World Hemophilia Day PR Newswire
Apr-10-17 11:52AM  Novo Nordisk A/S : NVO-US: Dividend Analysis : March 27th, 2017 (record date) : By the numbers : April 10, 2017 Capital Cube
Apr-09-17 07:22AM  5 Pharmaceutical Stocks With the Most Reliable Dividends Motley Fool
Apr-08-17 12:03AM  [$$] The Charms of Bayer and Novo Nordisk Barrons.com
Apr-07-17 12:00AM  Ailing Novo Seeks Cure With Diabetes Drug Targeting Fat Too Bloomberg
Apr-03-17 09:11AM  Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 March 2017) GlobeNewswire
09:07AM  The Latest from Sanofis Diabetes and Cardiovascular Franchise
Mar-31-17 03:29PM  Understanding Sanofis Valuation Compared to Peers Market Realist
03:29PM  Understanding Sanofis Valuation Compared to Peers
02:05PM  Consistent Performance Measurement May Improve Novartiss R&D
Mar-30-17 10:36AM  What Wall Street Analysts Estimate for GlaxoSmithKline
Mar-29-17 06:00AM  Emisphere Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Mar-28-17 05:39PM  Novo Nordisk: Positive CHMP Nod for Tresiba Label Expansion Zacks
05:39PM  Novo Nordisk: Positive CHMP Nod for Tresiba Label Expansion at Investopedia
11:07AM  Orexigen Inks Commercialization Deal for Contrave, Stock Up
07:37AM  GlaxoSmithKlines Valuation Compared to Its Peers Market Realist
07:37AM  GlaxoSmithKlines Valuation Compared to Its Peers
Mar-27-17 06:56PM  Citigroup Commercial Mortgage Trust 2017-P7 -- Moody's Assigns Provisional Ratings to Nine CMBS Classes of Citigroup Commercial Mortgage Trust 2017-P7 Moody's
06:56PM  Citigroup Commercial Mortgage Trust 2017-P7 -- Moody's Assigns Provisional Ratings to Nine CMBS Classes of Citigroup Commercial Mortgage Trust 2017-P7 at Moody's
08:00AM  New fast-acting mealtime insulin, Fiasp®, now approved and available in Canada for the treatment of diabetes PR Newswire
Mar-26-17 09:03AM  3 Tremendously Promising Diabetes Drugs Potentially on the Way Motley Fool
09:03AM  3 Tremendously Promising Diabetes Drugs Potentially on the Way at Motley Fool
Mar-25-17 06:00AM  Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin Business Wire
Mar-24-17 12:00PM  Novos Basal Insulin Gets CHMP Nod to Update Label at Investopedia
11:30AM  Novo Nordisks Hemophilia B Drug Gets CHMP Nod at Investopedia
Mar-22-17 08:05AM  Novo Nordisk Stock Trades Ex-Dividend Thursday at Investopedia
Mar-17-17 08:06AM  3 Top Diabetes Care Stocks to Buy in 2017 at Motley Fool
Mar-16-17 01:59PM  A drug company just struck a deal to discount the price of a lifesaving diabetes medication to $25
Mar-15-17 10:03AM  Sanofi and Voluntis Ink Global Pact for Diabetes at Investopedia
05:45AM  Once paid by Vertex, Trump's FDA pick would be tasked with regulating it at bizjournals.com
Mar-13-17 09:39AM  Novo Nordisk's Diabetes Unit Strong; Generic Pressure Stays
Mar-11-17 09:00AM  SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Novo Nordisk A/S and Encourages Investors with Losses to Contact the Firm Business Wire
Mar-10-17 10:50PM  NOVO NORDISK 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Novo Nordisk A/S (NVO) Business Wire
08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO Accesswire
02:33PM  Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of Curing Disease
11:41AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 - NVO PR Newswire
05:40AM  Heres Our Take On The Global Blood Therapeutics Inc (GBT) Rumors at Insider Monkey
Mar-09-17 05:14PM  Biotech Reporter Adam Feuerstein Will Be On Benzinga's PreMarket Prep Friday Morning
11:17AM  Novo Nordisk in Talks to Buy Global Blood Therapeutics (NVO,GBT) at Investopedia
10:30AM  March 13 Deadline Alert: Law Offices of Howard G. Smith Reminds Novo Nordisk A/S Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
10:28AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
09:04AM  Novo Nordisk Named on the FORTUNE 100 Best Companies to Work For® List for Ninth Consecutive Year PR Newswire
Mar-08-17 05:39PM  Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk
04:17PM  Why Global Blood Therapeutics Rocketed Higher Today at Motley Fool
12:01PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 NVO GlobeNewswire
11:49AM  Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) & Lead Plaintiff Deadline: March 13, 2017 GlobeNewswire
12:31AM  Novo Seen Missing Target of 40 Million Diabetics Treated by 2020
Mar-07-17 08:25AM  Lawsuit for Investors in Novo Nordisk A/S (ADR) (NYSE:NVO) Shares Announced by Shareholders Foundation Accesswire
Mar-06-17 02:15PM  NVO Lead Plaintiff Deadline Reminder: Hagens Berman Reminds Novo Nordisk Investors of March 13, 2017 Lead Plaintiff Deadline GlobeNewswire
Mar-05-17 04:56PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Novo Nordisk A/S to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
09:00AM  DEADLINE ALERT: Brower Piven Reminds Investors Of The March 13, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Novo Nordisk A/S (NVO) To Contact The Firm GlobeNewswire
Mar-03-17 10:50PM  NOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S (NVO) GlobeNewswire
09:51AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Mar-02-17 06:18PM  NVO DEADLINE NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important March 13 Deadline in Class Action NVO GlobeNewswire
02:25PM  Investor Alert: GPM Reminds Investors of the March 13 Deadline in the Class Action Lawsuit Against Novo Nordisk A/S Business Wire
10:40AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
09:30AM  Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International
Mar-01-17 06:43PM  Pricing to Remain Pharma Headline Risk in 2017
06:12AM  Novo Nordisk North American head quits for top job at Falck
02:03AM  Novo Nordisk replaces head of North American operations
Feb-28-17 04:05PM  NVO INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Novo Nordisk A/S Business Wire
03:42PM  Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma at Motley Fool
07:36AM  Pfizers Profitability and Financial Guidance
Feb-27-17 10:39AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
10:12AM  NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
Feb-24-17 08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO Accesswire
10:02AM  Patient Dies In Roche Hemophilia Study at Investopedia
Feb-23-17 11:45PM  Pawar Law Group Announces that a Securities Class Action Lawsuit has been filed Against Novo Nordisk A/S - NVO Accesswire
10:38AM  SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
Feb-22-17 11:39AM  NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 PR Newswire
09:30AM  Canadian News Media Challenged to See the Whole Picture When Reporting on Obesity PR Newswire
Feb-21-17 09:06AM  Sanofi Pasteur: Why Human Vaccines Matter
Feb-20-17 09:06AM  Sanofis Unique Foothold in Diabetes and Cardiovascular
Feb-17-17 10:50PM  NOVO NORDISK SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S (NVO) Business Wire
08:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO Accesswire
09:58AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-15-17 09:30AM  9 Top Pharmaceutical Stocks to Buy for the Dividends at Kiplinger
Feb-14-17 03:11PM  DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm Business Wire
01:58PM  NVO INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Novo Nordisk A/S Business Wire
10:18AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
Feb-13-17 01:29PM  NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-10-17 08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline NVO GlobeNewswire
10:23AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
Feb-09-17 09:33AM  Great Place to Work® and Fortune Name Novo Nordisk as one of the country's best workplaces for giving back PR Newswire
09:30AM  The Zacks Analyst Blog Highlights: Priceline, NextEra Energy, Schwab, Anadarko and Novo Nordisk
Feb-08-17 03:59PM  Top Analyst Reports for Priceline, Schwab & NextEera Energy
01:23PM  NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
10:45AM  Just 2 of the 13 Largest Drugmakers Have More Cash Than Debt -- Can You Guess Who They Are? at Motley Fool
Feb-07-17 02:14PM  Novo Nordisk A/S :NVO-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
12:33PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Novo Nordisk A/S NVO GlobeNewswire
10:45AM  Hemophilia Drug Market Competitive Ramps Up at Investopedia
10:37AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
10:30AM  Beaten-Down Valuation and a 3% Dividend Yield
Feb-06-17 06:26PM  Value Screeners Identify Top Sectors
10:50AM  Novo Nordisk A/S :NVO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.